In summary, although HOXC13-AS exerts oncogenic function by regulating the miR-383-3p/HMGA2 axis, it also provides new ideas for the treatment of nasopharyngeal carcinoma patients to a certain extent. This evidence concerns the gene HMGA2 and nasopharyngeal carcinoma.